Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer.
Ansari RH, Socinski MA, Edelman MJ, Belani CP, Gonin R, Catalano RB, Marinucci DM, Comis RL, Obasaju CK, Chen R, Monberg MJ, Treat J; Alpha Oncology Research Network. Ansari RH, et al. Among authors: monberg mj. Crit Rev Oncol Hematol. 2011 May;78(2):162-71. doi: 10.1016/j.critrevonc.2010.03.003. Epub 2010 Apr 21. Crit Rev Oncol Hematol. 2011. PMID: 20413322
Cost comparison of adverse event management among breast and ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors: analysis based on phase 3 clinical trials.
Fan L, Zhang Y, Maguire P, Muston D, Monberg M, Earla JR, Mihai A, Gulati P. Fan L, et al. Among authors: monberg m. J Mark Access Health Policy. 2022 Jun 8;10(1):2078474. doi: 10.1080/20016689.2022.2078474. eCollection 2022. J Mark Access Health Policy. 2022. PMID: 35693379 Free PMC article.
Correction to: Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer.
Elsea D, Fan L, Mihai A, Moustaid FE, Simmons D, Monberg M, Muston D. Elsea D, et al. Among authors: monberg m. Pharmacoecon Open. 2022 Nov;6(6):899. doi: 10.1007/s41669-022-00372-0. Pharmacoecon Open. 2022. PMID: 36107308 Free PMC article. No abstract available.
50 results